Literature DB >> 17546054

Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities.

H-Y Yang1, Y-Y Wen, Y-I Lin, L Pham, C-H Su, H Yang, J Chen, M-H Lee.   

Abstract

The 14-3-3sigma, upregulated by p53 in response to DNA damage, can have a positive-feedback impact driving p53 activities and is a human cancer epithelial marker downregulated in various tumors. However, the precise roles of 14-3-3sigma during tumorigenesis are not well characterized. Here, we show that 14-3-3sigma is a critical regulator of murine double minute oncogene (MDM2). 14-3-3sigma interacts with MDM2 at the RING domain. The C-terminal region of 14-3-3sigma binds to MDM2 very efficiently. Importantly, 14-3-3sigma overexpression leads to destabilization of MDM2 through enhancing MDM2 self-ubiquitination and accelerating turnover rate. Conversely, loss of 14-3-3sigma results in a significant increase in MDM2 protein. Moreover, live-cell images indicated that 14-3-3sigma can affect the location of MDM2 from the nucleus to the cytoplasm, and that MDM2-mediated cytoplasmic localization of p53 can be reversed by the presence of 14-3-3sigma. Significantly, we further showed that 14-3-3sigma causes MDM2 downregulation, thereby stabilizing p53 and inhibiting tumor growth in animal tumors. Also, 14-3-3sigma blocks MDM2-mediated retinoblastoma degradation and p53 NEDDylation. Our results provide evidence that 14-3-3sigma is a pivotal MDM2 regulator involved in blocking a variety of activities of MDM2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17546054     DOI: 10.1038/sj.onc.1210540

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2.

Authors:  Yifan Chen; Zhaomin Li; Zizheng Dong; Jenny Beebe; Ke Yang; Liwu Fu; Jian-Ting Zhang
Journal:  Mol Cancer Res       Date:  2017-01-13       Impact factor: 5.852

Review 2.  Plasma membrane receptor complexes.

Authors:  José Aker; Sacco C de Vries
Journal:  Plant Physiol       Date:  2008-08       Impact factor: 8.340

3.  FBXW7 is involved in Aurora B degradation.

Authors:  Chieh-Lin Teng; Yun-Chi Hsieh; Liem Phan; Jihyun Shin; Chris Gully; Guermarie Velazquez-Torres; Stephen Skerl; Sai-Ching J Yeung; Shih-Lan Hsu; Mong-Hong Lee
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

4.  Essential amino acid supplementation alters the p53 transcriptional response and cytokine gene expression following total knee arthroplasty.

Authors:  Jonathan B Muyskens; Ari Winbush; Douglas M Foote; Douglas W Turnbull; Hans C Dreyer
Journal:  J Appl Physiol (1985)       Date:  2020-09-03

5.  p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status.

Authors:  A Quintás-Cardama; C Hu; A Qutub; Y H Qiu; X Zhang; S M Post; N Zhang; K Coombes; S M Kornblau
Journal:  Leukemia       Date:  2016-11-25       Impact factor: 11.528

6.  COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ.

Authors:  H H Choi; C Gully; C-H Su; G Velazquez-Torres; P-C Chou; C Tseng; R Zhao; L Phan; T Shaiken; J Chen; S C Yeung; M-H Lee
Journal:  Oncogene       Date:  2011-05-30       Impact factor: 9.867

7.  14-3-3sigma, the double-edged sword of human cancers.

Authors:  Zhaomin Li; Jing-Yuan Liu; Jian-Ting Zhang
Journal:  Am J Transl Res       Date:  2009-06-08       Impact factor: 4.060

8.  Ubiquitination of mammalian AP endonuclease (APE1) regulated by the p53-MDM2 signaling pathway.

Authors:  C S Busso; T Iwakuma; T Izumi
Journal:  Oncogene       Date:  2009-02-16       Impact factor: 9.867

9.  Nuclear export regulation of COP1 by 14-3-3σ in response to DNA damage.

Authors:  Chun-Hui Su; Ruiying Zhao; Guermarie Velazquez-Torres; Jian Chen; Christopher Gully; Sai-Ching J Yeung; Mong-Hong Lee
Journal:  Mol Cancer       Date:  2010-09-15       Impact factor: 27.401

10.  14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence.

Authors:  Julia Schultz; Saleh M Ibrahim; Julio Vera; Manfred Kunz
Journal:  Mol Cancer       Date:  2009-07-30       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.